8 results match your criteria: "University and Polytechnic Hospital of la Fe[Affiliation]"

Article Synopsis
  • The study aimed to evaluate the impact of corticosteroids on ICU mortality in mechanically ventilated COVID-19 patients suffering from ARDS.
  • Conducted in 70 ICUs, the study included 1,835 patients, with 1,117 receiving corticosteroids; however, initial results showed no significant difference in ICU mortality between those treated and those untreated with corticosteroids.
  • While corticosteroid treatment appeared to provide short-term survival benefits, it led to increased ICU mortality after 17 days, particularly benefiting younger patients and those with severe ARDS.
View Article and Find Full Text PDF

Purpose: To describe and evaluate the main direct health costs, in routine clinical practice, of age-related macular degeneration (AMD) patients, from hospital perspective, in Spain.

Methods: Retrospective, multicenter, and observational study conducted on five third-level Spanish hospitals, between December 2018 and December 2019. The study included patients who were diagnosed of AMD before December 2018.

View Article and Find Full Text PDF

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial.

Dig Liver Dis

April 2019

Center for Biomedical Research in the Liver and Digestive Diseases Network (CIBERehd), Carlos III Health Institute, Madrid, Spain; Digestive Diseases Unit, University and Polytechnic Hospital of La Fe, Valencia, Spain.

Background: In APPRECIA trial, Crohn's disease (CD) patients undergoing intestinal resection were randomized to postoperative adalimumab (ADA) or azathioprine (AZA).

Aims: To evaluate health-related quality of life (HRQoL) in APPRECIA trial.

Methods: HRQoL was evaluated using disease-specific shortened Spanish version of the IBDQ (SIBDQ-9) and generic European Quality of Life-5 Dimensions (EQ-5D) questionnaires, completed at baseline and at weeks 24 and 52.

View Article and Find Full Text PDF

Background: Despite the improvement in the prognosis of lupus nephritis (LN), the cardiovascular morbimortality remains high. The early recognition and remission of flares, while trying to avoid the metabolic adverse effects of medication, must be mandatory.

Aim: The aim of our study was to assess the cardiovascular (CV) risk profile in a cohort of lupus patients with preserved kidney function after a nephritis episode, compared to patients without a nephritis flare.

View Article and Find Full Text PDF

Necrotising fasciitis in systemic lupus erythematosus: a case report and literature review.

Lupus Sci Med

November 2014

Department of Medicine , Centre for Rheumatology, University College of London, London , UK.

Necrotising fasciitis (NF) is a rare infection of the subcutaneous tissue, known to be rapidly progressive and potentially fatal. Patients with systemic lupus erythematosus (SLE) may be predisposed to this condition, and early clinical recognition can be difficult. We report a case of necrotising fasciitis in a 26-year-old woman with SLE.

View Article and Find Full Text PDF